These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26056726)

  • 21. Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance.
    Zheng W; Cao C; Liu Y; Yu Q; Zheng C; Sun D; Ren X; Liu J
    Acta Biomater; 2015 Jan; 11():368-80. PubMed ID: 25204523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-assembled multifunctional DNA nanospheres for biosensing and drug delivery into specific target cells.
    Bi S; Dong Y; Jia X; Chen M; Zhong H; Ji B
    Nanoscale; 2015 Apr; 7(16):7361-7. PubMed ID: 25825266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
    Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X
    Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery.
    Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A
    Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of nanodrugs for miRNA targeting in tumor cells.
    Yoo B; Ghosh SK; Kumar M; Moore A; Yigit MV; Medarova Z
    J Biomed Nanotechnol; 2014 Jun; 10(6):1114-22. PubMed ID: 24749405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LaF3:Ln mesoporous spheres: controllable synthesis, tunable luminescence and application for dual-modal chemo-/photo-thermal therapy.
    Lv R; Yang G; He F; Dai Y; Gai S; Yang P
    Nanoscale; 2014 Dec; 6(24):14799-809. PubMed ID: 25359551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chitosan nanospheres loaded with VEGF on adipose tissue transplantation: a preliminary report.
    Zhang MY; Ding SL; Tang SJ; Yang H; Shi HF; Shen XZ; Tan WQ
    Tissue Eng Part A; 2014 Sep; 20(17-18):2273-82. PubMed ID: 24559057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabrication of biocompatible and tumor-targeting hyaluronan nanospheres by a modified desolvation method.
    Zheng W; Li Y; Du J; Yin Z
    J Pharm Sci; 2014 May; 103(5):1529-37. PubMed ID: 24604299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
    Sypniewski D; Bednarek I; Gałka S; Loch T; Błaszczyk D; Sołtysik D
    Acta Pol Pharm; 2013; 70(1):87-97. PubMed ID: 23610963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.
    Gao S; Chen J; Dong L; Ding Z; Yang YH; Zhang J
    Eur J Pharm Biopharm; 2005 Aug; 60(3):327-34. PubMed ID: 15894474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
    Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
    Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles.
    Zhao P; Zheng M; Yue C; Luo Z; Gong P; Gao G; Sheng Z; Zheng C; Cai L
    Biomaterials; 2014 Jul; 35(23):6037-46. PubMed ID: 24776486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of two transfectors on delivery of 99mTc antisense DNA in tumor-bearing mice.
    Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ
    Mol Imaging Biol; 2006; 8(3):188-92. PubMed ID: 16534553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo.
    Spänkuch B; Heim S; Kurunci-Csacsko E; Lindenau C; Yuan J; Kaufmann M; Strebhardt K
    Cancer Res; 2006 Jun; 66(11):5836-46. PubMed ID: 16740723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisense MBD2 gene therapy inhibits tumorigenesis.
    Slack A; Bovenzi V; Bigey P; Ivanov MA; Ramchandani S; Bhattacharya S; tenOever B; Lamrihi B; Scherman D; Szyf M
    J Gene Med; 2002; 4(4):381-9. PubMed ID: 12124980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
    Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ tracking the intracellular delivery of antisense oligonucleotides by fluorescein doped silica nanoparticles.
    Zhang P; Wang TY; Xiong HM; Kong JL
    Talanta; 2014 Sep; 127():43-50. PubMed ID: 24913855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-functional alginic acid hybrid nanospheres for cell imaging and drug delivery.
    Guo R; Li R; Li X; Zhang L; Jiang X; Liu B
    Small; 2009 Mar; 5(6):709-17. PubMed ID: 19235799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploiting the protein corona around gold nanorods for loading and triggered release.
    Kah JC; Chen J; Zubieta A; Hamad-Schifferli K
    ACS Nano; 2012 Aug; 6(8):6730-40. PubMed ID: 22804333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense DNAs as targeted genetic medicine to treat cancer.
    Cho-Chung YS
    Arch Pharm Res; 2003 Mar; 26(3):183-91. PubMed ID: 12723929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.